Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study

Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study

Introduction Haematopoietic stem cell transplantation (HSCT) is a life-saving treatment for a number of haematological diseases. Graft versus host disease (GVHD) is its main complication and hampers survival. There is strong evidence that intestinal microbiota diversity of the recipient may increase...

Full description

Bibliographic Details
Main Authors: Lucrecia Yáñez, Silvia Jiménez-Jorge, Clara M Rosso-Fernández, Gema Labrador-Herrera, Nancy Rodríguez-Torres, María Eugenia Pachón-Ibáñez, Younes Smani, Francisco José Márquez-Malaver, Carmen Limón Ramos, Carlos Solano, Lourdes Vázquez-López, Mi Kwon, Joan Manuel Mora Barrios, Manuela Aguilar-Guisado, Ildefonso Espigado, Ariadna Pérez Martínez, Peña-Muñoz F, Rebeca Bailen Almorox
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/7/e034570.full

Internet

https://bmjopen.bmj.com/content/10/7/e034570.full

Similar Items